Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Subjects:

Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. by Hyung Suk Yang (20442438)

Subjects:

Experimental Setup and live ECG recording during an on-air primetime TV interview: On the left side, the science communicator was interviewed by Marco Dedola, director of the “Scie... by David Vagni (8060432)

Subjects:

Front and side images of the computer-aided design of the prostheses, including an interior perspective showing the location and size of the holes. by Long Li (6555)

Particle size distribution table of sand samples. by Kui Suo (20614613)

Subjects:

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

Analysis of Significantly Different Bacteria. by Xu Jia (187142)

Concurrent mixed methods design diagram. by Esario IV Daguman (21474116)

Subjects:

Outcomes and data gathering timeline. by Esario IV Daguman (21474116)

Subjects:

The guiding map. by Esario IV Daguman (21474116)

Subjects:

Summary of five key points guiding the Safe Steps evaluation and implementation. by Esario IV Daguman (21474116)

Subjects:

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. by Farrokh Habibzadeh (12256529)

Subjects:

Soil partice-size distribution. by Yonggang Huang (223155)

Effect of sample size on reproducibility. by Jan Willem Koten (17743224)

Average stability values (mean ± standard deviation) and statistical results. by Hyung Suk Yang (20442438)

Subjects:

Individual stability values for different gait events under various conditions. by Hyung Suk Yang (20442438)

Subjects:

Dynamic stability based on the Feasible Stability Region (FSR). by Hyung Suk Yang (20442438)

Subjects:

Sample size characteristics. by Alex Bawuah (21702688)

“…The lack of birthweight data is a significant challenge in monitoring the global prevalence of extreme birthweight, either low or high, and newborn health. …”

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)